Advertisement

Topics

Evotec-Aktie: Attraktiv mit hohem KGV

05:34 EDT 11 Sep 2017 | FinanzNachrichten

Evotecs Liste an Kooperationspartnern ist lang und klangvoll: Bayer, Sanofi, Pfizer, Boehringer Ingelheim, Novartis und zahlreiche weitere "Big Pharma" Unternehmen arbeiten mit den Hamburgern zusam...

Original Article: Evotec-Aktie: Attraktiv mit hohem KGV

NEXT ARTICLE

More From BioPortfolio on "Evotec-Aktie: Attraktiv mit hohem KGV"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Sanofi-Aventis
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...